Penetration of minocycline into lung tissues.

Br J Clin Pharmacol

Centre Hospitalier de Versailles, Départment de Biochimie-Pharmacologie-Toxicologie, Le Chesnay, France.

Published: September 1991

The penetration of minocycline into different lung tissues and bronchial mucus was studied in 17 patients undergoing pulmonary surgery for cancer. The patients received oral minocycline 100 mg at night for 3 days preceding surgery. Minocycline concentrations were measured in plasma samples collected before the operation and in tissues and mucus taken from in and around the part of the lung that was surgically removed. Mean tissue or mucus concentration to plasma concentration ratios were 3.78 +/- 1.10 for lung parenchyma, 4.04 +/- 1.31 for bronchial walls, 3.37 +/- 1.00 for pulmonary arterial walls, 1.99 +/- 1.80 for intraluminal mucus collected from bronchi located in healthy tissue proximal to the tumour, 5.16 +/- 3.26 for intraluminal mucus collected in a bronchus distal to the tumour, and 3.06 +/- 1.99 for catheter-collected mucus from the trachea and principal bronchi. These results indicate that minocycline is found in high concentration in all types of lung tissue and mucus in man.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1368539PMC
http://dx.doi.org/10.1111/j.1365-2125.1991.tb03920.xDOI Listing

Publication Analysis

Top Keywords

penetration minocycline
8
minocycline lung
8
lung tissues
8
tissue mucus
8
intraluminal mucus
8
mucus collected
8
mucus
7
+/-
6
lung
5
tissues penetration
4

Similar Publications

Fluoroquinolones and Biofilm: A Narrative Review.

Pharmaceuticals (Basel)

December 2024

Clinical Department of Medical, Surgical and Health Sciences, Trieste University, 34129 Trieste, Italy.

: Biofilm-associated infections frequently span multiple body sites and represent a significant clinical challenge, often requiring a multidisciplinary approach involving surgery and antimicrobial therapy. These infections are commonly healthcare-associated and frequently related to internal or external medical devices. The formation of biofilms complicates treatment, as they create environments that are difficult for most antimicrobial agents to penetrate.

View Article and Find Full Text PDF

Minocycline nanoplatform penetrates the BBB and enables the targeted treatment of Parkinson's disease with cognitive impairment.

J Control Release

January 2025

School of Pharmaceutical Sciences, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China. Electronic address:

Article Synopsis
  • Parkinson's disease (PD) is increasing globally due to aging, but effective treatments for its motor and cognitive symptoms are still lacking, with neuroinflammation and neuronal apoptosis worsening these conditions.
  • The study developed minocycline-loaded iron oxide nanoparticles (FeO-MIN NPs) that can cross the blood-brain barrier using near-infrared (NIR) irradiation, allowing targeted delivery to the brain.
  • The FeO-MIN NPs showed strong anti-inflammatory and antioxidative properties, protecting neurons and improving motor function and cognitive ability in PD mice, indicating their potential as a therapeutic option.
View Article and Find Full Text PDF
Article Synopsis
  • * The review covers in vitro data and pharmacokinetics of key antibiotics, emphasizing the importance of how these drugs penetrate lung tissues.
  • * Expert recommendations include increasing dosages of tigecycline and minocycline, considering nebulized polymyxin E and novel antibiotics for combination therapy, and exploring the potential of new treatments like sulbactam-durlobactam and zofusbactam.
View Article and Find Full Text PDF

Deciphering the Intracellular Action of the Antimicrobial Peptide A11 via an In-Depth Analysis of Its Effect on the Global Proteome of .

ACS Infect Dis

August 2024

Graduate Program in Biomedical Sciences, Faculty of Allied Health Sciences, Thammasat University, Khlong Luang, Pathum Thani 12120, Thailand.

The potential antimicrobial activity and low propensity to induce the development of bacterial resistance have rendered antimicrobial peptides (AMPs) as novel and ideal candidate therapeutic agents for the treatment of infections caused by drug-resistant pathogenic bacteria. The targeting of bacterial membranes by AMPs has been typically considered their sole mode of action; however, increasing evidence supports the existence of multiple and complementary functions of AMPs that result in bacterial death. An in-depth characterization of their mechanism of action could facilitate further research and development of AMPs with higher potency.

View Article and Find Full Text PDF

Lariat ethers are macrocyclic polyethers-crown ethers-to which sidearms are appended. 4,13-Diaza-18-crown-6 having twin alkyl chains at the nitrogens show biological activity. They exhibit antibiotic activity, but when co-administered at with an FDA-approved antibiotic, the latter's potency is often strongly enhanced.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!